Copyright
©The Author(s) 2017.
World J Hepatol. Jan 18, 2017; 9(2): 106-113
Published online Jan 18, 2017. doi: 10.4254/wjh.v9.i2.106
Published online Jan 18, 2017. doi: 10.4254/wjh.v9.i2.106
Figure 1 Study enrollment.
CRRT: Crrtcontinuous renal replacement therapycrrt; ICU: Intensive care unit; AVP: Arginine vasopressin.
Figure 2 Twenty-eight-day survival comparing second line vasopressors in catecholamine-resistant septic shock.
- Citation: Myc LA, Stine JG, Chakrapani R, Kadl A, Argo CK. Vasopressin use in critically ill cirrhosis patients with catecholamine-resistant septic shock: The CVICU cohort. World J Hepatol 2017; 9(2): 106-113
- URL: https://www.wjgnet.com/1948-5182/full/v9/i2/106.htm
- DOI: https://dx.doi.org/10.4254/wjh.v9.i2.106